Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $3.1M (11,673 shares) of Krystal Biotech, Inc. on Feb 24, 2026. Filing
- Last sale before this period: Jun 9, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Director | Sep 19, 2017 | Sep 16, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 27, 2026, Krystal Biotech, Inc.: sold 11,803 shares for $3.3M, under a disclosed plan (some held indirectly). 1 filing: 1
- Feb 26, 2026, Krystal Biotech, Inc.: sold 7,741 shares for $2.1M, under a disclosed plan (some held indirectly). 1 filing: 1
- Feb 25, 2026, Krystal Biotech, Inc.: sold 700 shares for $193K, under a disclosed plan (some held indirectly). 1 filing: 1
- Feb 24, 2026, Krystal Biotech, Inc.: sold 51,720 shares for $13.8M, under a disclosed plan; 37,895 shares acquired by exercising options (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.